Search

Your search keyword '"Wojciechowska C"' showing total 112 results

Search Constraints

Start Over You searched for: Author "Wojciechowska C" Remove constraint Author: "Wojciechowska C"
112 results on '"Wojciechowska C"'

Search Results

17. Ezetimibe added to statin therapy after acute coronary syndromes

19. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

21. Poster Session 5: Saturday 10 December 2011, 08:30-12:30 * Location: Poster Area

22. Moderated Posters session IV: Viability and recovery of systolic function. The echo approach * Friday 10 December 2010, 15:30-16:30

33. Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome

36. Impact of baseline level of 7-ketocholesterol on the rate of coronary reintervention in coronary artery disease patients--results of an observational study with questionnaire-based follow up

39. Poster session Friday 13 December - AM: 13/12/2013, 08:30-12:30 * Location: Poster area

40. The Role of Oxidative Stress and Inflammatory Parameters in Heart Failure.

41. Association of NT-proBNP and sST2 with Left Ventricular Ejection Fraction and Oxidative Stress in Patients with Stable Dilated Cardiomyopathy.

42. The Impact of Pharmacotherapy for Heart Failure on Oxidative Stress-Role of New Drugs, Flozins.

43. Pregnancy in Patients with Pulmonary Arterial Hypertension in Light of New ESC Guidelines on Pulmonary Hypertension.

44. Pathomechanisms of SARS-CoV-2 infection and development of atherosclerosis in patients with COVID-19: A review.

45. Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI?

46. Ceruloplasmin as Redox Marker Related to Heart Failure Severity.

47. Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy.

48. DIAGNOSTIC AND PREDICTIVE VALUE OF RIGHT HEART CATHETERIZATION-DERIVED MEASUREMENTS IN PULMONARY HYPERTENSION.

49. Decreased immunoreactivity of von Willebrand factor may reflect persistent nature of the endothelial dysfunction in non-ischemic heart failure.

50. Nitric Oxide Stroke Volume Index as a New Hemodynamic Prognostic Parameter for Patients with Pulmonary Arterial Hypertension.

Catalog

Books, media, physical & digital resources